Case Report

Published on 25 Jun 2024

Recurrence of an undifferentiated pleomorphic pulmonary artery sarcoma 8 years after initial presentation: a case report

in Cardio-Oncology

Baudouin Bourlond
Niccolo Maurizi
Panagiotis Antiochos
Ioannis Skalidis
Katarina Auf Der Springe
Claire Royer
Pierre Monney
Olivier Muller
Mathias Kirsch

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1378333

644 views

Original Research

Published on 14 Jun 2024

Cardiotoxicity of CPX-351 in children and adolescents with relapsed AML: a Children's Oncology Group report

in Cardio-Oncology

Kasey J. Leger
Michael J. Absalon
Biniyam G. Demissei
Amanda M. Smith
Robert B. Gerbing
Todd A. Alonzo
Hari K. Narayan
Betsy A. Hirsch
Jessica A. Pollard
Bassem I. Razzouk

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1347547

1,542 views

Case Report

Published on 13 Jun 2024

Case Report: Primary malignant mesothelioma of the left atrium easily misdiagnosed as myxoma

in Cardio-Oncology

Shuai Luo
Yao Li
Jin Li
Jiafei Zeng
Jinjing Wang

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1398311

1,161 views

Case Report

Published on 07 Jun 2024

Atrioventricular re-entrant tachycardia and atrioventricular node re-entrant tachycardia in a patient with cancer under chemotherapy: a case report and literature review

in Cardio-Oncology

Meiyan Dai
Yue Chen
Jin Qin

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1367893

1,136 views
1 citation

Case Report

Published on 17 May 2024

Case Report: Assessment of primary myxofibrosarcoma in the left atrium using multimodal ultrasonography

in Cardio-Oncology

Liyan Hu
Zhaohui Wang
Yu Chen
Xiaowei Zhang

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1378655

790 views

Original Research

Published on 16 May 2024

Sodium-glucose cotransporter 2 inhibitor dapagliflozin prevents ejection fraction reduction, reduces myocardial and renal NF-κB expression and systemic pro-inflammatory biomarkers in models of short-term doxorubicin cardiotoxicity

in Cardio-Oncology

V. Quagliariello
M. L. Canale
I. Bisceglia
M. Iovine
A. Paccone
C. Maurea
M. Scherillo
A. Merola
V. Giordano
G. Palma

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1289663

3,521 views
4 citations

Original Research

Published on 25 Apr 2024

Thyroid cancer and cardiovascular diseases: a Mendelian randomization study

in Cardio-Oncology

Yamei Gao
Zhijia Wang
Jinsheng Yu
Lijun Chen

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1344515

2,389 views

Original Research

Published on 04 Apr 2024

Prevalence and outcomes of atrial fibrillation in patients suffering prostate cancer: a national analysis in the United States

in Cardio-Oncology

Zhemin Pan
Xiao Xu
Xi Xu
Shengyong Wu
Zhensheng Zhang
Suxuan Liu
Zhijian Liu
Boxiang Tu
Chenxin Chen
Yingyi Qin

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1382166

1,693 views

Case Report

Published on 22 Mar 2024

Case Report: Two cases of advanced primary cardiac angiosarcoma treated with anlotinib and a retrospective analysis of the literature

in Cardio-Oncology

Pan Yang
Fu Xiong
Bingjing Zhu
Liang Gong
Chunlan Tang

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1363235

1,379 views

Original Research

Published on 21 Mar 2024

Exploring the effects of calycosin on anthracycline-induced cardiotoxicity: a network pharmacology, molecular docking, and experimental study

in Cardio-Oncology

Peng Zhu
Qianqian Ren
Ruizhi Zhang
Licai Zhang
Xiangwen Xia
Chuansheng Zheng
Tianhe Ye

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1286620

1,979 views
1 citation

Editorial

Published on 06 Mar 2024

Editorial: Interpretable predictive analytics for precision cardio-oncology preventive care

in Cardio-Oncology

Jiandong Zhou
Tong Liu
Leonardo Roever
Qingpeng Zhang

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1377749

1,133 views

Case Report

Published on 29 Feb 2024

Navigating P2Y12 inhibition in the labyrinth of cardio-oncology care: cangrelor bridging in patients with cancer

in Cardio-Oncology

Abdelrahman Ali
Poonam Jewani
Max Bourdillon
Efstratios Koutroumpakis
Shaden Khalaf
Konstantinos Charitakis
Kara Thompson
Konstantinos Marmagkiolis
Anita Deswal
Cezar Iliescu

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1337957

1,930 views
1 citation

Case Report

Published on 28 Feb 2024

Case Report: A case of third-degree atrioventricular block associated with primary cardiac lymphoma

in Cardio-Oncology

Jianping Liu
Yong Zheng
Weishan Zhang
Juan Xia
Yongheng Zhang
Long Tang

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1356134

1,428 views

Case Report

Published on 19 Feb 2024

Case Report: Sudden very late-onset near fatal PD1 inhibitor-associated myocarditis with out-of-hospital cardiac arrest after >2.5 years of pembrolizumab treatment

in Cardio-Oncology

Richard I. Lewis
Katharina Seuthe
Simon Lennartz
Jan-Phillip Weber
Nicole Kreuzberg
Karin Klingel
Paul J. Bröckelmann

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1328378

1,995 views
2 citations

Clinical Trial

Published on 07 Feb 2024

A prospective randomized controlled trial to determine the safety and efficacy of extracorporeal shock waves therapy for primary prevention of subclinical cardiotoxicity in breast cancer patients without a cardiovascular risk treated with doxorubicin

in Cardio-Oncology

Shinjeong Song
Joohyun Woo
HyunGoo Kim
Jun Woo Lee
Woosung Lim
Byung-In Moon
Kihwan Kwon

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1324203

1,382 views
1 citation

Systematic Review

Published on 02 Feb 2024

Risk of cardiovascular toxicity with combination of immune-checkpoint inhibitors and angiogenesis inhibitors: a meta-analysis

in Cardio-Oncology

Alessandro Inno
Antonello Veccia
Giorgio Madonia
Alvise Berti
Roberto Bortolotti
Lorena Incorvaia
Antonio Russo
Orazio Caffo
Stefania Gori

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2024.1309100

2,271 views

Navigation group

Articles

Recurrence of an undifferentiated pleomorphic pulmonary artery sarcoma 8 years after initial presentation: a case report

Cardiotoxicity of CPX-351 in children and adolescents with relapsed AML: a Children's Oncology Group report

Case Report: Primary malignant mesothelioma of the left atrium easily misdiagnosed as myxoma

Atrioventricular re-entrant tachycardia and atrioventricular node re-entrant tachycardia in a patient with cancer under chemotherapy: a case report and literature review

Case Report: Assessment of primary myxofibrosarcoma in the left atrium using multimodal ultrasonography

Sodium-glucose cotransporter 2 inhibitor dapagliflozin prevents ejection fraction reduction, reduces myocardial and renal NF-κB expression and systemic pro-inflammatory biomarkers in models of short-term doxorubicin cardiotoxicity

Thyroid cancer and cardiovascular diseases: a Mendelian randomization study

Prevalence and outcomes of atrial fibrillation in patients suffering prostate cancer: a national analysis in the United States

Case Report: Two cases of advanced primary cardiac angiosarcoma treated with anlotinib and a retrospective analysis of the literature

Exploring the effects of calycosin on anthracycline-induced cardiotoxicity: a network pharmacology, molecular docking, and experimental study

Editorial: Interpretable predictive analytics for precision cardio-oncology preventive care

Navigating P2Y12 inhibition in the labyrinth of cardio-oncology care: cangrelor bridging in patients with cancer

Case Report: A case of third-degree atrioventricular block associated with primary cardiac lymphoma

Case Report: Sudden very late-onset near fatal PD1 inhibitor-associated myocarditis with out-of-hospital cardiac arrest after >2.5 years of pembrolizumab treatment

A prospective randomized controlled trial to determine the safety and efficacy of extracorporeal shock waves therapy for primary prevention of subclinical cardiotoxicity in breast cancer patients without a cardiovascular risk treated with doxorubicin

Risk of cardiovascular toxicity with combination of immune-checkpoint inhibitors and angiogenesis inhibitors: a meta-analysis